The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3-and 6-month response rates in trials of biological agents

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)186-192
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number1
DOIs
Publication statusPublished - 2010

Cite this